Scholars@Duke
Journal cover image

Predictors of reduced relative dose intensity (RDI) in patients with early-stage breast cancer (ESBC) receiving adjuvant chemotherapy (CT).

Publication ,  Conference
Lyman, GH; Crawford, J; Dale, DC
Published in: BREAST CANCER RESEARCH AND TREATMENT
2004

Duke Scholars

Gary Herbert Lyman
Author Gary Herbert Lyman Medicine, Medical Oncology

Published In

BREAST CANCER RESEARCH AND TREATMENT

ISSN

0167-6806

Publication Date

2004

Volume

88

Start / End Page

S49 / S49

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., Crawford, J., & Dale, D. C. (2004). Predictors of reduced relative dose intensity (RDI) in patients with early-stage breast cancer (ESBC) receiving adjuvant chemotherapy (CT). In BREAST CANCER RESEARCH AND TREATMENT (Vol. 88, pp. S49–S49).
Lyman, G. H., J. Crawford, and D. C. Dale. “Predictors of reduced relative dose intensity (RDI) in patients with early-stage breast cancer (ESBC) receiving adjuvant chemotherapy (CT).” In BREAST CANCER RESEARCH AND TREATMENT, 88:S49–S49, 2004.
Lyman GH, Crawford J, Dale DC. Predictors of reduced relative dose intensity (RDI) in patients with early-stage breast cancer (ESBC) receiving adjuvant chemotherapy (CT). In: BREAST CANCER RESEARCH AND TREATMENT. 2004. p. S49–S49.
Lyman, G. H., et al. “Predictors of reduced relative dose intensity (RDI) in patients with early-stage breast cancer (ESBC) receiving adjuvant chemotherapy (CT).” BREAST CANCER RESEARCH AND TREATMENT, vol. 88, 2004, pp. S49–S49.
Journal cover image

Published In

BREAST CANCER RESEARCH AND TREATMENT

ISSN

0167-6806

Publication Date

2004

Volume

88

Start / End Page

S49 / S49

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences